alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

116TH CONGRESS 

1ST SESSION H. R. 986 

To provide that certain guidance related to waivers for State innovation 

under the Patient Protection and Affordable Care Act shall have no 

force or effect. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 6, 2019 

Ms. KUSTER of New Hampshire (for herself, Mr. BEYER, and Mr. COURTNEY) 

introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and 

Means, for a period to be subsequently determined by the Speaker, in 

each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To provide that certain guidance related to waivers for State 

innovation under the Patient Protection and Affordable 

Care Act shall have no force or effect. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Protecting Americans 

5 with Preexisting Conditions Act of 2019’’. 


kjohnson on DSK79L0C42 with BILLS
2 

•HR 986 IH

1 SEC. 2. PROVIDING THAT CERTAIN GUIDANCE RELATED TO 

2 WAIVERS FOR STATE INNOVATION UNDER 

3 THE PATIENT PROTECTION AND AFFORD4 ABLE CARE ACT SHALL HAVE NO FORCE OR 

5 EFFECT. 

6 Beginning April 1, 2019, the Secretary of Health and 

7 Human Services and the Secretary of the Treasury may 

8 not take any action to implement, enforce, or otherwise 

9 give effect to the guidance entitled ‘‘State Relief and Em10 powerment Waivers’’ (83 Fed. Reg. 53575 (October 24, 

11 2018)), and the Secretaries may not promulgate any sub12 stantially similar guidance or rule. 

Æ 


kjohnson on DSK79L0C42 with BILLS
- Skip to main content
- About Us
- Contact Us
- FAQs
-  Language Assistance ****    - English
  - español
  - 中文: 繁體版
  - Việt-ngữ
  - 한국어
  - Tagalog
  - Русский 

U.S. Department of Education

U.S. Department of Education

        - Student Loans
        - Grants
        - Laws
        - Data

            - taxonomy view
            - South Carolina 

# South Carolina 

# South Carolina 

                      -  August 12, 2021  U.S. Department of Education Approves South Carolina’s Plan for Use of American Rescue Plan Funds to Support K-12 Schools and Students, Distributes Remaining $705 Million to State  
Today, the U.S. Department of Education (Department) announced the approval of South Carolina’s American Rescue Plan Elementary and Secondary School Emergency Relief (ARP  ESSER) plan and distributed remaining ARP ESSER funds to them.
  **Tags:**South CarolinaAmerican Rescue PlanPress Releases

## How Do I Find...?

                      - Student loans, forgiveness
                      - Higher Education Rulemaking
                      - College accreditation
                      - Every Student Succeeds Act (ESSA)
                      - FERPA
                      - FAFSA
                      - 1098, tax forms
                      - More...

## Information About...

                      - Elevating Teaching
                      - Early Learning
                      - Engage Every Student
                      - Unlocking Career Success
                      - Cybersecurity

----

*Our mission* is to promote student achievement and preparation for global competitiveness by fostering educational excellence and ensuring equal access.

          - Student Loans
          - Repaying Loans
          - Defaulted Loans
          - Loan Forgiveness
          - Loan Servicers
          - Grants & Programs
          - Apply for Pell Grants
          - Grants Forecast
          - Apply for a Grant

          - Laws & Guidance
          - Every Student Succeeds Act (ESSA)
          - FERPA
          - Civil Rights
          - IDEA Website
          - Data & Research
          - Education Statistics
          - Postsecondary Education Data
          - ED Data Express
          - Nation's Report Card
          - What Works Clearinghouse
          - Open Data Platform
          - COVID Relief Data

          - About Us
          - Contact Us
          - ED Offices
          - Jobs
          - Press Releases
          - FAQs
          - Recursos en español
          - Budget, Performance
          - Privacy Program
          - Homeroom Blog

----

          - Notices
          - FOIA
          - Privacy Policy
          - Accessibility
          - Security
          - Information Quality
          - Inspector General
          - Whitehouse.gov
          - USA.gov
          - Benefits.gov
          - Regulations.gov
[Federal Register Volume 62, Number 48 (Wednesday, March 12, 1997)]
[Notices]
[Page 11433]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6214]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY
[FRL-5708-1]


Scientific Counselors Board Executive Committee Meeting

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Federal Advisory Committee Act, Public Law 92-
463, as amended (5 U.S.C., App. 2), notice is hereby given that the 
Environmental Protection Agency (EPA), Office of Research and 
Development's (ORD), Board of Scientific Counselors (BOSC), will hold 
its Executive Committee Meeting, April 7-8, 1997, at the Hyatt 
Arlington Hotel, 1325 Wilson Boulevard, Arlington, Virginia. On Monday, 
April 7, the meeting will begin at 1:00 pm and will recess at 5:00 pm, 
and on Tuesday, April 8, the meeting will begin at 8:00 am and will 
adjourn at 4:30 pm. All times noted are Eastern time. Agenda items 
include, but are not limited to, BOSC Operating Principles, Laboratory 
Peer Review Discussion, ORD Research Plan Evaluation: Methods 
Development, Use of Peer Review in ORD, and Research Plan for Arsenic 
in Drinking Water. Anyone desiring a draft BOSC agenda may fax their 
request to Shirley R. Hamilton (202) 260-0929. The meeting is open to 
the public. Any Member of the public wishing to make comments at the 
meeting, should contact Shirley Hamilton, Designated Federal Officer, 
Office of Research and Development (8701), 401 M Street, SW., 
Washington, DC 20460; by telephone at (202) 260-0468. In general, each 
individual making an oral presentation will be limited to a total time 
of three minutes.

FOR FURTHER INFORMATION CONTACT: Shirley R. Hamilton, Designated 
Federal Officer, U.S. Environmental Protection Agency, Office of 
Research and Development, NCERQA (MC8701), 401 M Street, SW., 
Washington, DC 20460, 202-260-0468.

    Dated March 5, 1997.
Henry L. Longest II,
Acting Assistant Administrator for Research and Development.
[FR Doc. 97-6214 Filed 3-11-97; 8:45 am]
BILLING CODE 6560-50-M
Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION

906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of A.P. Pharma, Inc. (the Company) on Form 10-Q for the period ending
September 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Ronald J. Prentki, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------



|                                     
|-------------------------------------
|/s/ Ronald J. Prentki                
|Ronald J. Prentki,                   
|President and Chief Executive Officer

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION

906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Quarterly Report of A.P. Pharma, Inc. (the Company) on Form 10-Q for the period ending September 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), I,
Gregory H. Turnbull, Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------



|                               
|-------------------------------
|/s/ Gregory H. Turnbull        
|Gregory H. Turnbull,           
|Interim Chief Financial Officer
# C_2022326EN.01000302.xml

| 29.8.2022 | EN | Official Journal of the European Union | C 326/3 |
| --- | --- | --- | --- |

29.8.2022

EN

Official Journal of the European Union

C 326/3

---

Appeal brought on 2 March 2022 by MO against the judgment of the General Court (First Chamber) delivered on 21 December 2021 in Case T-587/20, MO v Council

(Case C-165/22 P)

(2022/C 326/04)

Language of the case: French

Parties

Appellant: MO (represented by: A. Guillerme, avocate)

Other party to the proceedings: Council of the European Union

By order of 15 July 2022, the Court (Tenth Chamber) dismissed the appeal as, in part, manifestly inadmissible and, in part, manifestly unfounded and ordered the appellant to bear her own costs.

---
3,613

0

2,677

6,290

BallotsCounted

27

57

0

84

BallotsRejected

NEVADA

Mail,Fax,Email

Election/Registrar's

Office

Internet

DM

V

Public

Assistance

Office

DisabilitiesAgency

Military

RecruitmentOffice

OtherState

Agency

RegistrationDrives

Registration:Other

134,680

155,007

136,014

173,864

61,922

50,342

1,160 62 774 2,548

RegistrationFormSource

TotalRegisteredVoters

1,678,883

SectionA-VoterRegistration

RegistrationFormsReceived

716,373

ConfirmationNotificationsSent

260,568

Polling

Place

UOCAVA Absentee Provisional

Ballot

EarlyVote

Center

Voteby

Mail

Turnout:

Other

343,722

702,021

66,824

6,849 2,324 6,342 50

SectionF-TurnoutbyMethod

CountedFull Counted

Part

Rejected Provisional:

Other

2,324

4,533

0 0

SectionE-ProvisionalBallots

UniformedService

Non-militaryOverseas

Other

SectionB-UOCAVA

3,047

3,943

0

6,990

BallotsTransmitted

TOTAL TOTAL

ProvisionalBallotTotal:6,857 TurnoutTotal:1,128,492

Select: NEVADA

TOTAL

 

 

 

 

 

 

 

 

                          

  

2016EAVSDataBrief 

U i
<PAGE>

EXHIBIT 99.2
------------
                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of PGI, Incorporated (the "Registrant") on
Form 10-QSB for the period ended December 31, 2002 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Laurence A.
Schiffer, Chief Financial Officer of the Registrant, certify as of the date
hereof that:

(1)  The Report fully complies with the requirements of section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(2)  The information contained in the Report fairly represents, in all material
     respects, the financial condition and results of operations of the
     Registrant.



/s/ Laurence A. Schiffer

Laurence A. Schiffer
Chief Financial Officer
March 31, 2003
# C_2023314EN.01000901.xml

| 4.9.2023 | EN | Official Journal of the European Union | C 314/9 |
| --- | --- | --- | --- |

4.9.2023

EN

Official Journal of the European Union

C 314/9

---

Judgment of the General Court of 12 July 2023 — Multiópticas v EUIPO — Nike Innovate (Representation of two black geometrical shapes)

(Case T-487/22) (1)

(EU trade mark - Opposition proceedings - Application for EU figurative mark representing two black geometrical shapes - Earlier EU and national figurative marks mó - Relative ground for refusal - No damage to reputation - Non-similarity of the signs - Article 8(5) of Regulation (EU) 2017/1001)

(2023/C 314/12)

Language of the case: English

Parties

Applicant: Multiópticas S. Coop. (Madrid, Spain) (represented by: M. López Camba and A. Lyubomirova Geleva, lawyers)

Defendant: European Union Intellectual Property Office (represented by: E. Markakis, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO: Nike Innovate CV (Beaverton, Oregon, United States)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 2 June 2022 (Case R 1762/2021-4)

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Multiópticas S. Coop. and the European Union Intellectual Property Office (EUIPO) to bear their own costs. |
| --- | --- |

2.

Orders Multiópticas S. Coop. and the European Union Intellectual Property Office (EUIPO) to bear their own costs.

---

(1)  OJ C 368, 26.9.2022.

---
# C_2022389EN.01000702.xml

| 10.10.2022 | EN | Official Journal of the European Union | C 389/7 |
| --- | --- | --- | --- |

10.10.2022

EN

Official Journal of the European Union

C 389/7

---

Request for a preliminary ruling from the Landgericht Düsseldorf (Germany) lodged on 22 July 2022 — EM v Roompot Service B.V.

(Case C-497/22)

(2022/C 389/09)

Language of the case: German

Referring court

Landgericht Düsseldorf

Parties to the main proceedings

Applicant and appellant: EM

Defendant and respondent: Roompot Service B.V.

Question referred

Must the first sentence of Article 24(1) of Regulation (EU) No 1215/2012 (1) be interpreted as meaning that a contract which is concluded between a private individual and a commercial lessor of holiday homes in relation to the short-term letting of a bungalow in a holiday park operated by the lessor, and which provides for cleaning at the end of the stay and the provision of bed linen as further services in addition to the mere letting of the bungalow, is subject to the exclusive jurisdiction of the State in which the rented property is situated, irrespective of whether the holiday bungalow is owned by the lessor or by a third party?

---

(1)  Regulation (EU) No 1215/2012 of the European Parliament and of the Council of 12 December 2012 on jurisdiction and the recognition and enforcement of judgments in civil and commercial matters (recast) (OJ 2012 L 351, p. 1).

---
Submitted February 3,

reversed March 22, 2017

#### In the Matter of S. A. M., a Person Alleged to have a Mental Illness. STATE OF OREGON, *Respondent, v.*S. A. M., *Appellant.*

Jackson County Circuit Court

16CC05769; A163149

393 P3d 744

Charles Kochlacs filed the brief for appellant.

Ellen F. Rosenblum, Attorney General, Benjamin Gutman, Solicitor General, and Christopher Page, Assistant Attorney General, filed the brief for respondent.

Before Sercombe, Presiding Judge, and Flynn, Judge, and DeHoog, Judge.

*554PER CURIAM

Appellant in this mental commitment case appeals an order committing him to the custody of the Mental Health Division for a period not to exceed 180 days. ORS 426.130. On appeal, in his first assignment of error,1 appellant contends that the trial court committed plain error when it failed to advise him of his right to subpoena witnesses as required by ORS 426.100(1).2 The state concedes that the court’s failure constitutes plain error and requires reversal. We agree, and accept the state’s concession. *See State v. R. D. S.,*271 Or App 687, 688, 352 P3d 84 (2015) (“A trial court’s failure to advise a person as required is not only error, but it is plain error that we exercise our discretion to consider despite an appellant’s failure to raise and preserve the issue at the hearing.” (Internal quotation marks omitted.)); *State v. Z. A. B.,*264 Or App 779, 780, 334 P3d 480, *adh’d to as modified on recons,*266 Or App 708, 338 P3d 802 (2014) (failure to advise of right to subpoena witnesses alone constitutes plain error justifying reversal); *State v. M. L. R.,*256 Or App 566, 570-72, 303 P3d 954 (2013) (observing that “plain error review of violations of ORS 426.100(1) is justified by the nature of civil commitment proceedings, the relative interests of the parties in those proceedings, the gravity of the violation, and the ends of justice” and exercising discretion to correct the plain error (internal quotation marks omitted)). Furthermore, for the reasons set forth in *M. L. R.,*we exercise our discretion to correct the trial court’s error in this case. *See also R. D. S.,*271 Or App at 688-89 (exercising discretion to correct plain error in failing to advise appellant of her right to subpoena witnesses where, although the record showed that appellant’s counsel was aware of appellant’s right to subpoena witnesses, it did not show that appellant’s counsel had informed appellant of that right); *State v. V. B.,*264 Or App 621, 623-24, 333 P3d 1100 (2014) (rejecting the state’s argument that the failure to advise appellant of her right to subpoena witnesses was *555harmless because she was represented by counsel, and exercising discretion to correct the trial court’s plain error).

Reversed.

1

 Appellant also raises a second assignment of error challenging the trial court’s commitment order. However, we need not address that assignment of error in light of our resolution of appellant’s first assignment.

2

 Pursuant to ORS 426.100(1), the court shall advise the person alleged to have a mental illness of, among other things, “[t]he right to subpoena witnesses.”
Exhibit
      32.2





CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      Section #1350,


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002





In
      connection with the Quarterly Report on Form 10-Q (“Form 10-Q”) of Galaxy
      Nutritional Foods, Inc. (the "Company") for the period ended June 30, 2007
      as
      filed with the Securities and Exchange Commission on the date hereof, I,
      Salvatore J. Furnari, Chief Financial Officer of the Company, certify, pursuant
      to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, that:





(1)  The
      Form
      10-Q fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)  The
      information contained in the Form 10-Q fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.


/s/
                Salvatore J. FurnariSalvatore
                J. FurnariChief
                Financial Officer
                August
                  14, 2007
<TABLE> <S> <C>



<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          FEB-24-1996
<PERIOD-END>                               NOV-25-1995
<CASH>                                           8,939
<SECURITIES>                                         0
<RECEIVABLES>                                   33,039
<ALLOWANCES>                                         0
<INVENTORY>                                     43,142
<CURRENT-ASSETS>                               101,544
<PP&E>                                          52,051
<DEPRECIATION>                                  22,521
<TOTAL-ASSETS>                                 152,368
<CURRENT-LIABILITIES>                           30,825
<BONDS>                                          2,932
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           100
<OTHER-SE>                                     114,705
<TOTAL-LIABILITY-AND-EQUITY>                   152,368
<SALES>                                        163,984
<TOTAL-REVENUES>                               163,984
<CGS>                                           73,637
<TOTAL-COSTS>                                  155,960
<OTHER-EXPENSES>                                   950
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 455
<INCOME-PRETAX>                                  7,616
<INCOME-TAX>                                     2,513
<INCOME-CONTINUING>                              5,103
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     5,103
<EPS-PRIMARY>                                     0.52
<EPS-DILUTED>                                     0.52
        


</TABLE>
<TABLE> <S> <C>

<PAGE>

<ARTICLE>                       5
<MULTIPLIER>                    1000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          FEB-28-1998
<PERIOD-END>                               AUG-23-1997
<CASH>                                           3,239
<SECURITIES>                                         0
<RECEIVABLES>                                   12,115
<ALLOWANCES>                                         0
<INVENTORY>                                     52,400
<CURRENT-ASSETS>                                89,065
<PP&E>                                          67,372
<DEPRECIATION>                                  27,532
<TOTAL-ASSETS>                                 141,669
<CURRENT-LIABILITIES>                           27,656
<BONDS>                                            635
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           104
<OTHER-SE>                                     109,032
<TOTAL-LIABILITY-AND-EQUITY>                   141,669
<SALES>                                         65,005
<TOTAL-REVENUES>                                65,005
<CGS>                                           33,685
<TOTAL-COSTS>                                   69,537
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 183
<INCOME-PRETAX>                                (4,133)
<INCOME-TAX>                                   (1,405)
<INCOME-CONTINUING>                            (2,728)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,728)
<EPS-PRIMARY>                                   (0.28)
<EPS-DILUTED>                                   (0.28)
        


</TABLE>